Stomach paralysis drug trial halted midway

NCT ID NCT04026997

First seen Apr 06, 2026 · Last updated May 12, 2026 · Updated 5 times

Summary

This study tested an oral drug called CIN-102 in 72 adults with gastroparesis (stomach paralysis) caused by diabetes or unknown reasons. The goal was to see if the drug safely helps food leave the stomach faster and eases nausea. The trial was stopped early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROPARESIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site 101

    Chula Vista, California, 91910, United States

  • Research Site 102

    Boston, Massachusetts, 02215, United States

  • Research Site 103

    Louisville, Kentucky, 40202, United States

  • Research Site 104

    Monroe, Louisiana, 71201, United States

  • Research Site 105

    Tulsa, Oklahoma, 74104, United States

  • Research Site 106

    Philadelphia, Pennsylvania, 19140, United States

  • Research Site 107

    Jackson, Tennessee, 38305, United States

  • Research Site 109

    Great Neck, New York, 11023, United States

  • Research Site 110

    Kansas City, Kansas, 66045, United States

  • Research Site 111

    Atlanta, Georgia, 30322, United States

  • Research Site 112

    Marrero, Louisiana, 70072, United States

  • Research Site 113

    Las Vegas, Nevada, 89123, United States

  • Research Site 114

    Jacksonville, Florida, 32224, United States

  • Research Site 115

    Rapid City, South Dakota, 57702, United States

  • Research Site 117

    Miami, Florida, 33134, United States

  • Research Site 118

    Miami, Florida, 33183, United States

  • Research Site 119

    Summerville, South Carolina, 29485, United States

  • Research Site 120

    Winston-Salem, North Carolina, 27103, United States

  • Research Site 121

    Omaha, Nebraska, 68134, United States

Conditions

Explore the condition pages connected to this study.